VYNE THERAPEUTICS INC (VYNE)
US92941V3087 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -29.08M | -28.45M | -23.21M | -73.33M | -255.57M | |||
| Depreciation Amortization | N/A | 0.00 | 70.00K | 110.00K | 340.00K | |||
| Change In Working Capital | -1.17M | 60.00K | 2.28M | 4.78M | -40.33M | |||
| Interest Paid | N/A | N/A | 0.00 | 2.39M | 3.94M | |||
| Other non cash items | 2.40M | 3.05M | -8.34M | 12.08M | 158.48M | |||
| OPERATING CASH FLOW | -27.84M | -25.34M | -29.20M | -56.37M | -137.08M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -110.00K | |||
| Other Investing Activity | -65.92M | -57.35M | 15.67M | 1.03M | 89.22M | |||
| INVESTING CASH FLOW | -65.92M | -57.35M | 15.67M | 1.03M | 89.11M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | 0.00 | -36.43M | 0.00 | |||
| Stock Issued/Repurchased | 82.61M | 82.39M | 1.65M | 76.50M | 61.95M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -290.00K | -140.00K | |||
| FINANCING CASH FLOW | 82.61M | 82.39M | 1.65M | 39.78M | 61.81M | |||
| Exchange Rate Effect | N/A | N/A | N/A | 0.00 | 0.00 | |||
| CHANGE IN CASH | -11.16M | -301.00K | -11.88M | -15.56M | 13.84M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -27.84M | -25.34M | -29.20M | -56.37M | -137.08M | |||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -110.00K | |||
| FREE CASH FLOW | -27.84M | -25.34M | -29.20M | -56.37M | -137.19M | |||
All data in USD